Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Jan 2, 2026 · Filed Jan 6, 2026
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
grant award
Code A — grant or award
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Derivative exercise or conversion — not an open-market buy.
Director sold ~$1.2M of Regeneron Pharmaceuticals
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.